research use only

GRL0617 DUB inhibitor

Cat.No.S6845

GRL0617 is a potent, selective and competitive noncovalent inhibitor of severe acute respiratory syndrome (SARS-CoV) papain-like protease (PLPro)/deubiquitinase with IC50 of 0.6 μM and Ki of 0.49 μM. This compound inhibits SARS-CoV viral replication in Vero E6 cells with EC50 of 15 microM and has no associated cytotoxicity.
GRL0617 DUB inhibitor Chemical Structure

Chemical Structure

Molecular Weight: 304.39

Quality Control

Batch: S684501 DMSO]65 mg/mL]false]Ethanol]22 mg/mL]false]Water]Insoluble]false Purity: 99.86%
99.86

Cell Culture, Treatment & Working Concentration

Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Vero E6 Antiviral assay 48 hrs Antiviral activity against SARS coronavirus in african green monkey Vero E6 cells assessed as inhibition of replication after 48 hrs, EC50=13.1μM 19645480
Vero E6 Antiviral assay 0.1 to 50 uM 48 hrs Antiviral activity against SARS-CoV infected in african green monkey Vero E6 cells at 0.1 to 50 uM after 48 hrs, EC50=14.5μM 23231439
Click to View More Cell Line Experimental Data

Chemical Information, Storage & Stability

Molecular Weight 304.39 Formula

C20H20N2O

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 1093070-16-6 -- Storage of Stock Solutions

Synonyms N/A Smiles CC1=C(C=C(C=C1)N)C(=O)NCCC2=CC=CC3=CC=CC=C32

Solubility

In vitro
Batch:

DMSO : 65 mg/mL ( (213.54 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : 22 mg/mL

Water : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

Targets/IC50/Ki
PLPro/deubiquitinase [1]
(Cell-free assay)
0.49 μM(Ki)
PLPro/deubiquitinase [1]
(Cell-free assay)
0.6 μM
References

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.

Signaling Pathway Map